Current Projects

Justin McArthur, MBBS, MPH

• Center for Novel Therapeutics for HIV-associated Cognitive Disorders; Grant # 1PO30MH075673
• Center for Novel therapeutics for HIV-associated Cognitive Disorders: Developmental Core; Grant # 5P30MH075673-05
• Center for Novel Therapeutics for HIV-associated Cognitive Disorders: Clinical Outcomes Core; Grant # 5P30MH075673-05
• Center for Novel Therapeutics for HIV-associated Cognitive Disorders: Surrogate Markers Core; Grant # 5P30MH075673-05
• Center for Novel Therapeutics for HIV-associated Cognitive Disorders: Animal Core; Grant # 3P30MH075673-04S1A1

Ned Sacktor, MD

• Oxidative Stress markers and HIV Dementia; Grant # 5R01MH071150-05
• HIV Dementia and Sensory Neuropathy in Uganda; Grant # 5R21MH083465-02

Janice Clements, PhD

• CNS and Peripheral Viral Reservoirs/SIV Model of HIV HAART; Grant # 5P01MH070306-07
• Minocycline Inhibits Immune Reactivation of CNS SIV; Grant # 5R01NS055648-05

M. Christine Zink, DVM, PhD

• Training Veterinarians for Careers in Biomedical Research; Grant # 2T32RR007002-34A1
• IDO Regulation in the SIV Model of HIV CNS Disease; Grant # 5R01MH085554-03
• Minocycline Immune Effects on SIV CNS Disease; Grant # 1R01MH087233-01A1

Joseph Mankoski, DVM, PhD

• Mechanisms of HIV-Induced PNS Disease: The SIV Macaque Model; Grant # 5R01NS055651-04
• Mechanisms of HIV-Induced PNS Disease: The SIV Macaque Model; Grant # 3R01NS055651-04S1

Robert Cotter, Ph.D.

• Purchase of a Triple Quadropole Mass Spectrometer for Multiple Reaction Monitoring

Norman Haughey, PhD

• Perturbation of Amyloid Processing in HAND; Grant #1R21AG034849-01A1
• Interaction of Alcohol with HIV-Protein; Grant #�3R01AA017408-03S1
• Interaction of Alcohol with HIV-Protein; Grant # 5R01AA017408-04
• Dysfunctions of Sphingolipid and Sterol Metabolism in HIV-Dementia; Grant # 5R01MH077542-04

Amanda Brown, PhD

• Osteopontin: An inflammatory mediator in neurodegenerative diseases
• The Role of Osteopontin in HIV-Associated Neurocognitive Disorder R21MH095646-01

Barbara Slusher, PhD, MAS

• JHU/Pharma collaborative partnership to conduct high throughput screening to identify novel neurotherapeutics
• JHU/Pharma partnership to develop GCPII inhibitors for neurodegenerative disorders